MedTrace Logo

Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy

NCT01953380 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2017-04-12

No results posted yet for this study

Summary

The purpose of this study is to determine whether extended information given to patients with contact allergy improves knowledge, treatment efficacy and daily functioning.

Conditions

  • Dermatitis, Allergic Contact

Interventions

BEHAVIORAL

extended information

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Andreas Sonesson, MD PhD · Region Skåne, Hudkliniken SUS

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01953380 on ClinicalTrials.gov